Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting

Applied Radiation and Isotopes

Volumn 64, Issue 9, 2006, Pages 971-978

  Liu, Guozheng ^a   Dou, Shuping ^a   He, Jiang ^a   Yin, Dongguang ^a   Gupta, Suresh ^a   Zhang, Surong ^a   Wang, Yi ^a   Rusckowski, Mary ^a   Hnatowich, Donald J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

DNA analog; Pretargeting; Radiolabeling; Rhenium 188

Indexed keywords

ANTIBODIES; BIOMEDICAL ENGINEERING; DNA; PH; RADIOISOTOPES; RADIOTHERAPY; RHENIUM; TUMORS;

DNA ANALOG; PRETARGETING; RADIOLABELING; RHENIUM-188;

OLIGOMERS;

CHELATING AGENT; MERCAPTOACETYLTRIGLYCINE MORPHOLINO OLIGOMER RE 188; MERTIATIDE TC 99M; MORPHOLINE DERIVATIVE; OLIGOMER; RADIOPHARMACEUTICAL AGENT; RHENIUM 188; UNCLASSIFIED DRUG; OLIGOPEPTIDE; ORGANOMETALLIC COMPOUND; PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER; RADIOISOTOPE; RHENIUM; RHENIUM MERCAPTOACETYLTRIGLYCINE; RHENIUM-MERCAPTOACETYLTRIGLYCINE;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CONJUGATION; DRUG STABILITY; HYBRIDIZATION; ISOTOPE LABELING; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; RADIOACTIVITY; ANIMAL; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METHODOLOGY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ISOTOPE LABELING; MICE; MORPHOLINES; OLIGOPEPTIDES; ORGANOMETALLIC COMPOUNDS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RHENIUM;

EID: 33746334480     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2006.04.005     Document Type: Article

References (25)

1. 99mTc-aquaion labels peptide to an unprecedented high specific activity. J. Nucl. Med. 40 (1999) 1913-1917
2. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts. Cancer Res. 53 (1993) 3524-3529
3. 188Re-labeled bivalent hapten: biodistribution and dosimetry studies. J. Nucl. Med. 42 (2001) 146-153
4. 186Re-labeled NR-LU-10 whole antibody in LS174 T colonic tumor-bearing mice. Cancer Res. 50 (1990) 7973-7978
5. 3 as prosthetic groups for labeling amines and peptides: approaches with pre- and postconjugate labeling. Nucl. Med. Biol. 25 (1998) 621-631
6. 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation. Nucl. Med. Commun. 25 (2004) 731-736
7. 3 with technetium-99 m. Appl. Radiat. Isot. 48 (1997) 587-594
8. Hnatowich D.J., Qu T., Chang F., et al. Labeling peptides with technetium-99 m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine. J. Nucl. Med. 39 (1998) 56-64
9. 186Re in human ovarian cancer xenografts. Int. J. Radiat. Oncol. Biol. Phys. 38 (1997) 813-823
10. 99mTc-labeled morpholino, a DNA analog. J. Nucl. Med. 43 (2002) 384-391
11. 3-conjugated morpholino oligomers. Bioconjug. Chem 13 (2002) 893-897
12. 99mTc. Nucl. Med. Biol. 30 (2003) 207-214
13. +-labeled N,N-bis(2-pyridylmethyl)-4-aminobutyric acid. Bioconjug. Chem. 15 (2004) 1441-1446
14. Liu G., He J., Dou S., et al. Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake. Eur. J. Nucl. Med. Mol. Imag. 31 (2004) 417-424
15. 99mTc-labeled morpholinos for radiopharmaceutical applications. Eur. J. Nucl. Med. 28 (2001) 1682-1689
16. Pearson D.A., Lister-James J., McBride W.J., et al. Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies. J. Med. Chem. 39 (1996) 1361-1371
17. Polyakov V., Sharma V., Dahlheimer J.L., et al. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjug. Chem. 11 (2000) 762-771
18. 186Re-MAGIPG-D612 monoclonal antibody in nude mice bearing colon cancer xenografts. Cancer Biother. Radiopharm. 12 (1997) 55-62
19. 99mTc-neutrophil elastase inhibitor in monkeys. J. Nucl. Med. 41 (2000) 363-374
20. 99mTc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. Bioconjug. Chem. 11 (2000) 345-351
21. 2: a new anti-CEA antibody fragment for radioimmunotherapy (abstract). J. Nucl. Med. 30 (1989) 793
22. 3 chelate for radioimmunotherapy of cancer: a technical protocol. J. Nucl. Med. 34 (1993) 1953-1963
23. 3 for technetium-99m labeling of DNA. Nucl. Med. Biol. 24 (1997) 425-432
24. 188Re. J. Nucl. Med. 41 (2000) 887-895
25. Zuckier L.S., Dohan O., Li Y., et al. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. J. Nucl. Med. 45 (2004) 500-507